Rx (Prescription Medicine)
USD $ 30.00
Lupizotib 60mg Tablet 是一种用于治疗特定类型癌症的靶向治疗药物。其活性成分为 Lupizotib，属于酪氨酸激酶抑制剂类药物。这些抑制剂通过阻断参与癌细胞生长和转移的特定蛋白质发挥作用。通过抑制这些通路，Lupizotib 有助于减缓或停止疾病的进展。
Lupizotib 适用于这些靶向通路过度活跃的特定癌症的治疗。剂量和治疗时长由合格的医疗专业人员根据个体患者的病情、对疗法的反应以及所治疗癌症的类型和阶段确定。务必严格按照医生的处方服用 Lupizotib。
常见不良反应可能包括疲劳、恶心、腹泻、皮疹以及血细胞计数变化。更严重的不良反应也可能发生，如出现新症状或原有症状加重，患者应立即向医生报告。Lupizotib 应储存在室温下，避免潮湿和热源，并置于儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Pazopanib. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
